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Adult Lead Poisoning Cluster 
 from Ayurvedic Product Usage in Iowa, 2011 
LEAD EXPOSURE INDEX CASE and CLUSTER 
IDENTIFICATION 
In April 2011, an adult white non-Hispanic male seen at a neurology clinic 
for a two-year follow up of a previous intracranial hemorrhage 
demonstrated worsening neurological deficits. A heavy metal panel 
reported a blood lead level of 93.6 µg/dL. The patient reported ingesting 
two ayurvedic products obtained in India since June 2010. Test results for 
one product labeled “bhasma” revealed 19,400 mg/Kg lead and 1,430 
mg/Kg arsenic. More than 100 adults living in the same rural, 
predominantly Caucasian, community who also used ayurvedic products 
were tested over the following six months and over 200 ayurvedic product 
samples were submitted for heavy metal testing. The company in India 
supplying the products reported 1,600 customers in the USA and Europe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BACKGROUND: 
According to a 2008 National Institutes of Health National Center for 
Complementary and Alternative Medicine (NCCAM) study, complementary 
and alternative medicine (CAM) is used by 38% of the U.S. adult 
population.  People of all backgrounds use CAM, but use is greater among 
women and those with higher levels of education and income. Nonvitamin, 
nonmineral natural products are the most commonly used therapy among 
adults – 17.7% 
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FINDINGS 
45 out of 117 Iowans 16 years of age or older tested between April 2011-
January 2012 who declared using ayurvedic products were identified as cases 
with an  elevated blood lead level (EBL) of 10 µg/dL or greater. Four adults had 
elevated blood mercury levels (10 ng/ml or greater). The mean age of the Iowa 
cases was 62 years (range 45 - 74). The mean initial EBL was 37 µg/dL (range 
11-94) with 32 of 45 (71%) having initial EBL results of 25 µg/dL or greater.   
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Descriptors for the cluster population do not follow traditional demographic 
profiles, with much of the information obtained indirectly, limiting the ability to 
quantify the findings. Some of the people involved in this cluster reside in Iowa 
part-time or on an extended temporary basis as they pursue their interest in 
alternative lifestyle philosophies and medicine. Many had travelled to India for 
an initial treatment at the ayurvedic medicine clinic from which they were 
purchasing their ayurvedic products. Those most likely to have used products 
that intentionally contained heavy metals mixed with herbs (the rasa shastra 
class of ayurvedic medicines) were reportedly seeking alternative treatment 
options for serious medical conditions such as cardiovascular disease, stroke, 
and cancer. Over 95% were white and non-Hispanic. Products from the same 
clinic were involved in the lead poisoning of a pregnant Iowa woman from the 
same town as this cluster in 2007 who was diagnosed with a blood lead level 
of 102 µg/dL. 
PRODUCT TESTING 
 
Product testing revealed high levels of lead, mercury, arsenic, and other heavy 
metals in numerous products. Analysis was performed by the State Hygienic 
Laboratory at the University of Iowa, Ankeny using ICP/MS, and the EPA 6020 B 
method. Many dilutions were required due to the high levels encountered. 
Subsequent limited mercury speciation testing by Thermo Fisher Scientific found 
no organic and low inorganic mercury in the five products tested. The mercury 
present in the 97 products was most likely elemental, explaining the lack of acute 
mercury poisoning experienced by this cluster of adults.   
Not all samples were homogeneous. 
Products were received as pills, pastes, liquids, and powders. 
Analysis was done by weight as received. 
Only one blood lead test result was reported for an Iowa child using ayurvedic 
products  from the same supplier (parent also tested) with a resulting BLL of <5 
µg/dL.  Known adult blood lead tests linked to product usage from the same 
supplier for non-Iowa residents included four tests with BLLs <10 µg/dL, and 
four test results ranging from 23-55 µg/dL. These reports included people from 
California, New Mexico, Bermuda, and Wisconsin.  
Ayurvedic Medicine – an Introduction  
Excerpts from  NCCAM online materials 
Ayurvedic medicine (also called Ayurveda) is one of the world’s oldest 
medical systems. It originated in India and has evolved there over thousands 
of years. Ayurvedic medicine continues to be practiced in India, where nearly 
80 percent of the population uses it exclusively or combined with 
conventional (Western) medicine.  Ayurvedic practice involves the use of 
medications that typically contain herbs, metals, minerals, or other materials. 
 
In the United States more than 200,000 U.S. adults had used Ayurvedic 
medicine in the previous year according to the 2007 National Health 
Interview Survey.  
Product photos provided by State Hygienic Laboratory at the University of Iowa. 
LIMITATIONS 
 
The ability to correlate specific product exposure to persons with abnormal 
test results was limited. Many of the people using the ayurvedic products 
declined to participate in the epidemiologic investigation. Most products 
submitted for testing had handwritten labels and were not identified by a lot 
or batch number from the supplier. Some products with similar or identical 
names had dissimilar test results.  For this reason, a list of the products 
tested by name and their test results is of limited value as a predictor of risk.  
 
In the United States, Ayurvedic medications are regulated as dietary 
supplements. As such, they are not required to meet the safety and efficacy 
standards for conventional medicines. For this Iowa cluster, the FDA had 
limited ability to intervene because the products were reported by the users 
to be obtained directly from a supplier outside of the USA. Ayurvedic 
products purchased in the county of residence in Iowa did not demonstrate 
heavy metal contamination. 
CONCLUSIONS – PUBLIC HEALTH CONCERNS 
 
The clinic outside of the U.S. supplying the products acknowledged a 
problem with contamination by a sub-contractor, in part due to the findings 
of heavy metals in  products that were meant to be entirely herbal.  Their  
products from the rasa shastra class of ayurvedic medications were 
designed to contain heavy metals mixed with herbs, which they claim would 
have had no toxicity if the sub-contractor had manufactured them correctly 
using ancient methods. Whether or not products containing heavy metals 
can be rendered safe for human consumption remains controversial.  There 
was no recall of the products. This was the second known lead poisoning 
caused by this clinic’s products in Iowa since 2007. 
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The use of alternative medicine 
practices and products continues 
to expand into the mainstream 
population in the USA. Users may 
have an increased risk of 
exposure to toxic substances, 
especially when the products are 
manufactured outside of the USA. 
Consumers and medical 
practitioners need to be aware of 
the potential risks and proactively 
discuss the use of all 
supplements to determine the 
need for testing or intervention.   
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